Barclays’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-51
| Closed | -$5K | – | 4379 |
|
|
2023
Q1 | $5K | Hold |
51
| – | – | ﹤0.01% | 4157 |
|
|
2022
Q4 | $7K | Hold |
51
| – | – | ﹤0.01% | 4178 |
|
|
2022
Q3 | $26K | Hold |
51
| – | – | ﹤0.01% | 3855 |
|
|
2022
Q2 | $44K | Sell |
51
-26
| -34% | -$22.4K | ﹤0.01% | 3774 |
|
|
2022
Q1 | $193K | Hold |
77
| – | – | ﹤0.01% | 3338 |
|
|
2021
Q4 | $197K | Buy |
+77
| New | +$197K | ﹤0.01% | 2835 |
|
|
2021
Q3 | – | Hold |
0
| – | -$1K | – | 4101 |
|
|
2021
Q2 | – | Hold |
0
| – | -$1K | – | 4044 |
|
|
2021
Q1 | – | Hold |
0
| – | -$1K | – | 3871 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3502 |
|
|
2020
Q2 | – | Sell |
-11
| Closed | -$51K | – | 3921 |
|
|
2020
Q1 | $51K | Buy |
+11
| New | +$51K | ﹤0.01% | 3096 |
|